Associations between selected biomarkers and prognosis in population-based pancreatic cancer tissue microarray

Cancer Research

Volumn 69, Issue 7, 2009, Pages 2950-2955

  Takikita, Mikiko ^a   Altekruse, Sean ^a   Lynch, Charles F ^b   Goodman, Mark T ^c   Hernandez, Brenda Y ^c   Green, Mark ^c   Cozen, Wendy ^d   Cockburn, Myles ^d   Sibug Saber, Maria ^d   Topor, Marie ^e   Zeruto, Chris ^e   Abedi Ardekani, Behnoush ^a   Reichman, Marsha E ^a   Hewitt, Stephen M ^a,f  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e INFORMATION MANAGEMENT SERVICES INC   (United States)

^f Advanced Technology Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD5 ANTIGEN; CHROMOGRANIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MUCIN 1; MUCIN 2; MUCIN 5AC; NEURON SPECIFIC ENOLASE; PROTEIN P53; SYNAPTOPHYSIN; SYNDECAN 1; TUMOR MARKER;

ADULT; AGE; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CONFIDENCE INTERVAL; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; RACE DIFFERENCE; SEX DIFFERENCE; SURVIVAL TIME; TISSUE MICROARRAY; COHORT ANALYSIS; IMMUNOHISTOCHEMISTRY; METABOLISM; MICROARRAY ANALYSIS; PANCREAS TUMOR; PATHOLOGY; REGISTER; UNITED STATES;

COHORT STUDIES; HAWAII; HUMANS; IMMUNOHISTOCHEMISTRY; IOWA; LOS ANGELES; MICROARRAY ANALYSIS; PANCREATIC NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; TUMOR MARKERS, BIOLOGICAL;

EID: 66149100988     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3879     Document Type: Article

References (17)

1. Sahmoun AE, DÄgostlno RA, Jr., Bell RA, Schwenke DC. International variation in pancreatic cancer mor- tality for the period 1955-1998. Eur J Epidemiol 2003;18: 801-816.
2. Espey DK, Wu XC, Swan J, Wiggins C, et al. Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer 2007;110:2119-2152
3. Singh M, Maitra A. Precursor lesions of pancreatic cancer: molecular pathology and clinical implications. Pancreatology 2007;7:9-19.
4. Kure S, Kaneko T, Takeda S, Inoue S, Nakao A. Analysis of long-term survivors after surgical resection for invasive pancreatic cancer. HPB Oxford 2005;7:129-134
5. Tonini G, Pantano F, Vincenzi B, Gabbrielli A, Coppola R, Sanüni D. Molecular prognostic factors in patients with pancreatic cancer. Expert Opin Ther Targets 2007; 11:1553-69.
6. Goodman MT, Hernandez BY, Hewitt S, et ol. Tissues from population-based cancer registries: a novel ap- proach to increasing research potential. Hum Pathol 2005;36:812-820
7. Kononen J, Bubendorf L1 Kallioniemi A1 et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-847
8. Yonezawa S, Nakomura A, Horinouchi M, Sato E. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms. J Hepato- biliary Pancreat Surg 2002;9:328-341
9. Cox DR. Regression models and life tables (with discussion). J R Stat Soc Series B 1972;34:187-202.
10. Mantel N, Haenszel W. Statistical aspects of the analysis of data from, retrospective studies of disease. J Natl Cancer Inst 1959;22:719-748.
11. Kaplan EL, Meier P. Nonparametrlc estimation from incomplete observations. J Am Stat Assoc 1958:53: 457-481.
12. Osako M, Yonezawa S, Slddikl B, et al. Immunohls- tochemical study of mucin carbohydrates and core proteins in human pancreatic tumors. Cancer 1993;71: 2191-2199.
13. Rosai J. Ackerman's Surgical Pathology 9th ed. Baltimore: Mosby; 2004. p. 1083-1085.
14. Utsunomiya T, Yonezawa S, Sakamoto H, et al. Expression of MUCl and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Clin Cancer Res 1998;4:2605-2614.
15. Giuntoli RLII, Rodriguez GC, Whitaker RS, Dodge R, Voynow JA. Mucin gene expression in ovarian cancers. Cancer Res 1998;58:5546-5550.
16. Terada T, Ohta T, Sasaki M, Nakanuma Y, Kim YS. Expression of MUC apomucins in normal pancreas and pancreatic tumours. J Pathol 1996;180:160-165.
17. Nokomura A, Horinouchi M, Goto M, et al. New classification of pancreatic Intraductal paplllary- mucinous tumour by mucin expression: its relation- ship with potential for malignancy. J Pathol 2002; 197:201-210.